I'm 13lbs away from goal...Thank you! Elizabeth My Clinician was kind, informative, gave a clear understanding of expectations, what was needed and future follow ups and doasge changes
Some for medical necessity, others for self-improvement
Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial
One of them is Akkermansia muciniphila a "highly-promising" probiotic with the potential to help prevent and treat obesity and diabetes, according to a 2017 study potential being a key word here
Increasingly, employees are telling their employers that they want access to these medications, and many employers would like to offer plans that cover them
The Bottom Line The appeal of needle-free GLP-1 options is understandable, but the current evidence does not support sublingual semaglutide drops or weight loss patches as effective alternatives to proven treatments